Increased hepatocyte turnover and inhibition of woodchuck hepatitis B virus replication by adefovir In vitro do not lead to reduction of the closed circular DNA
- 1 July 2000
- journal article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 32 (1) , 139-146
- https://doi.org/10.1053/jhep.2000.8701
Abstract
The aim of this study was to evaluate the inhibitory effect of the nucleotide analogue adefovir on woodchuck hepatitis B virus (WHV) replication and, in particular, to determine whether the pool of covalently closed circular DNA (cccDNA) could be reduced by adefovir treatment in primary cultures of woodchuck hepatocytes isolated from a chronic carrier. Strong reduction of WHV-DNA synthesis (90%) and secretion (up to 98%) was observed with all 3 doses of adefovir used (1, 10, and 100 μmol/L), whereas in the absence of the drug, high amounts of viral particles were continuously secreted in the culture medium until the end of the study (27 days). Secretion of envelope proteins and viral RNA levels remained constant both in the adefovir-treated and -untreated cultures for the entire course of the study. Intracellular core protein levels declined by approximately 50% in all the cultures, independent of adefovir treatment. There was no indication of cccDNA loss in the adefovir-treated hepatocyte cultures even when cell turnover was induced for 14 days by the addition of epidermal growth factor (EGF) to the culture medium. Our data show that adefovir has a very strong inhibitory effect on WHV-DNA synthesis in chronically infected primary hepatocyte cultures and indicate that cccDNA is a very stable molecule that appears to be efficiently transmitted to the dividing hepatocytes.Keywords
This publication has 35 references indexed in Scilit:
- A One-Year Trial of Lamivudine for Chronic Hepatitis BNew England Journal of Medicine, 1998
- Hepatitis B viruses and cancerogenesisBiomedicine & Pharmacotherapy, 1998
- Hepatitis B virus, the vaccine, and the control of primary cancer of the liverProceedings of the National Academy of Sciences, 1997
- Clinical Experience with Famciclovir against Hepatitis B VirusIntervirology, 1997
- Hepatitis B Virus ImmunopathogenesisAnnual Review of Immunology, 1995
- The Half-Life of Duck Hepatitis B Virus Supercoiled DNA in Congenitally Infected Primary Hepatocyte CulturesVirology, 1994
- Inhibitory effect of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) on human and duck hepatitis B virus infectionAntiviral Research, 1993
- Marked in vivo antiretrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine, a selective anti-human immunodeficiency virus agent.Proceedings of the National Academy of Sciences, 1989
- Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cellsPublished by Elsevier ,1986
- Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediatePublished by Elsevier ,1982